Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.
Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials

Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.

Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.

experimental therapy
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Ashley Yeager | Apr 2, 2020
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
Remdesivir Works Against Coronaviruses in the Lab
Remdesivir Works Against Coronaviruses in the Lab
Abby Olena | Mar 20, 2020
The antiviral disables RNA replication machinery in MERS and SARS viruses. Can it beat back SARS-CoV-2?
Two Experimental Drugs Effective at Treating Ebola
Two Experimental Drugs Effective at Treating Ebola
Catherine Offord | Aug 13, 2019
REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.
Experimental Ebola Treatments Approved for Use in Uganda
Experimental Ebola Treatments Approved for Use in Uganda
Catherine Offord | Jun 19, 2019
The announcement comes as the country prepares for possible spread of the virus from Democratic Republic of Congo.
FDA Cracks Down on Purveyors of Stem Cell Treatments
FDA Cracks Down on Purveyors of Stem Cell Treatments
Ashley P. Taylor | Dec 21, 2018
The agency cites safety concerns with customers of Genetech who reported getting E. coli infections and sends letters to other stem cell companies reminding them to follow the rules.
Federal Trade Commission Takes Action Against Stem Cell Clinics
Federal Trade Commission Takes Action Against Stem Cell Clinics
Ashley P. Taylor | Oct 19, 2018
The FTC, in its first crack down on the industry, gets two California companies selling unproven treatments to stop their false advertising and pay a fine.
Ebola Update: More Experimental Treatments, Health Workers at Risk
Ebola Update: More Experimental Treatments, Health Workers at Risk
Catherine Offord | Aug 23, 2018
The number of cases in Democratic Republic of Congo’s latest outbreak of the virus has now surpassed 100.  
More Vaccinations, Experimental Drugs as Potential Ebola Contacts Rise
More Vaccinations, Experimental Drugs as Potential Ebola Contacts Rise
Sukanya Charuchandra | May 30, 2018
The World Health Organization predicts the number of cases in Democratic Republic of Congo will rise up to 300 by July.  
Ebola Update: Funding, Vaccines, and More Deaths in DRC
Ebola Update: Funding, Vaccines, and More Deaths in DRC
Catherine Offord | May 23, 2018
A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.